ZAMPOGNA, MARTA

Nome completo

ZAMPOGNA, MARTA

Afferenza

Universita' degli Studi di MILANO

Mostra records

Risultati 1 - 5 di 5 (tempo di esecuzione: 0.002 secondi).

Sequential Treatment for Osteoporosis After Teriparatide: A Real-Life Long-Term Comparison Between Zoledronic Acid and Denosumab

2025 A. Ghielmetti, G. Grassi, M. Zampogna, G. Mantovani, I. Chiodini, C. Eller-Vainicher

Identifying risk factors for pregnancy and lactation-associated osteoporosis: insights from an Italian survey in PLAO patients and controls

2025 G. Grassi, M. Zampogna, A. Atlasova, S. Rondinella, A. Ghielmetti, G. Siracusano, I. Chiodini, G. Mantovani, C. Eller-Vainicher

Response to: Letter to the Editor from Fitzpatrick et al: Zoledronate after denosumab discontinuation: Is repeated administrations more effective than single infusion?

2024 G. Grassi, A. Ghielmetti, M. Zampogna, I. Chiodini, M. Arosio, G. Mantovani, C. Eller-Vainicher

Zoledronate after denosumab discontinuation: Is repeated administrations more effective than single infusion?

2024 G. Grassi, A. Ghielmetti, M. Zampogna, I. Chiodini, M. Arosio, G. Mantovani, C. Eller Vainicher

Bone Disease in Long-Term Lung Transplant Survivors

2023 G. Grassi, E. Cairoli, L.M.S. Gentile, I. Chiodini, M. Zampogna, A. Ghielmetti, L.C. Morlacchi, V. Rossetti, L. Rosso, I. Righi, M. Nosotti, M. Arosio, F. Blasi, C. Eller Vainicher

Titolo	Data di pubblicazione	Autori	Tipo	Abstract
Sequential Treatment for Osteoporosis After Teriparatide: A Real-Life Long-Term Comparison Between Zoledronic Acid and Denosumab	2025	Ghielmetti, AlbertoGrassi, GiorgiaZampogna, MartaMantovani, GiovannaChiodini, IacopoEller-Vainicher, Cristina + -	Article (author)	-
Identifying risk factors for pregnancy and lactation-associated osteoporosis: insights from an Italian survey in PLAO patients and controls	2025	Grassi, GiorgiaZampogna, MartaAtlasova, AnnaRondinella, SaraGhielmetti, AlbertoSiracusano, GiordanaChiodini, IacopoMantovani, GiovannaEller-Vainicher, Cristina	Article (author)	-
Response to: Letter to the Editor from Fitzpatrick et al: Zoledronate after denosumab discontinuation: Is repeated administrations more effective than single infusion?	2024	Grassi, GiorgiaGhielmetti, AlbertoZampogna, MartaChiodini, IacopoArosio, MauraMantovani, GiovannaEller-Vainicher, Cristina	Article (author)	-
Zoledronate after denosumab discontinuation: Is repeated administrations more effective than single infusion?	2024	Grassi, GiorgiaGhielmetti, AlbertoZampogna, MartaChiodini, IacopoArosio, MauraMantovani, GiovannaEller Vainicher, Cristina	Article (author)	-
Bone Disease in Long-Term Lung Transplant Survivors	2023	Grassi, GiorgiaCairoli, ElisaGentile, Lucrezia Maria SilvanaChiodini, IacopoZampogna, MartaGhielmetti, AlbertoMorlacchi, Letizia CorinnaRossetti, ValeriaRosso, LorenzoRighi, IlariaNosotti, MarioArosio, MauraBlasi, FrancescoEller Vainicher, Cristina + -	Article (author)	-

IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

ZAMPOGNA, MARTA

Sequential Treatment for Osteoporosis After Teriparatide: A Real-Life Long-Term Comparison Between Zoledronic Acid and Denosumab

Identifying risk factors for pregnancy and lactation-associated osteoporosis: insights from an Italian survey in PLAO patients and controls

Response to: Letter to the Editor from Fitzpatrick et al: Zoledronate after denosumab discontinuation: Is repeated administrations more effective than single infusion?

Zoledronate after denosumab discontinuation: Is repeated administrations more effective than single infusion?

Bone Disease in Long-Term Lung Transplant Survivors